Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
AMRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.43B
Close$
$11.15
33.2% downside
Current Fair Value
33.2% downsideOvervalued by 33.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.43 Billion |
|---|---|
| Enterprise Value | $7.92 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.23 |
| Beta | 1.26 |
| Outstanding Shares | 328,933,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 44.89 |
|---|---|
| PEG | -19.6 |
| Price to Sales | 2.38 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.41 |
| Enterprise Value to EBIT | -79.12 |
| Enterprise Value to Net Income | 132 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$0.17
Average shareholder expectationRevenue Estimate
$719.66 M
Average shareholder expectationNext Earnings Call
Expected Date
July 30, 2026
EPS Estimate
$0.24
Average shareholder expectationRevenue Estimate
$760.56 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 226.60% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.04%▼ 49.98% |
|---|---|
| Total Invested | $59.40M▼ 97.01% |
| Investors Holding | 11▼ 306.00% |
ESG Score
No data